Gustav Victor Rudolf Born

From WikiMD's Food, Medicine & Wellness Encyclopedia

Gustav Victor Rudolf Born

Gustav Victor Rudolf Born (29 July 1921 – 16 April 2018) was a prominent British pharmacologist and academic. He is renowned for his pioneering research in the field of platelet biology, particularly in understanding the mechanisms of blood clotting and the prevention of thrombosis. Born's work has had a significant impact on the development of antiplatelet drugs, which are crucial in the treatment of cardiovascular diseases.

Early Life and Education[edit | edit source]

Born was born in Göttingen, Germany, the son of the famous physicist Max Born, who was awarded the Nobel Prize in Physics in 1954. Due to the rise of the Nazi regime in Germany, the Born family, being of Jewish heritage, fled to the United Kingdom in 1933. Gustav Born continued his education in Britain, eventually studying medicine at the University of Edinburgh, where he graduated with a medical degree.

Career[edit | edit source]

After completing his medical studies, Born focused on research in pharmacology, particularly in the area of hematology. He held various academic positions throughout his career, including a significant tenure at King's College London, where he was Professor of Pharmacology from 1973 to 1983. Born's research was instrumental in elucidating the process by which platelets aggregate, leading to blood clot formation. His work in the development of the platelet aggregation test has been a fundamental tool in hematology and pharmacology.

Contributions to Pharmacology[edit | edit source]

Gustav Born's contributions to the field of pharmacology are vast. His research on the mechanisms of platelet aggregation has paved the way for the development of antiplatelet therapy, which is vital in the management of coronary artery diseases and the prevention of myocardial infarction and stroke. Born's studies on the effects of low-dose aspirin on platelet function have significantly influenced the use of aspirin in cardiovascular disease prevention.

Legacy[edit | edit source]

Gustav Born's legacy in pharmacology and medicine is marked by his contributions to our understanding of blood clotting mechanisms and his role in the development of therapeutic strategies to prevent thrombosis. His work has saved countless lives and continues to influence the field of cardiovascular medicine.

Selected Publications[edit | edit source]

Throughout his career, Born published numerous influential papers and articles that have contributed significantly to the field of pharmacology and hematology. Some of his most notable publications include studies on platelet aggregation and the pharmacological effects of aspirin on blood clotting.

Awards and Honors[edit | edit source]

In recognition of his contributions to science and medicine, Gustav Born received several awards and honors. His achievements have been acknowledged by the scientific community worldwide, further cementing his status as a leading figure in pharmacology.

Death[edit | edit source]

Gustav Victor Rudolf Born passed away on 16 April 2018. His death marked the loss of a pioneering scientist whose work has had a lasting impact on the field of pharmacology and the treatment of cardiovascular diseases.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD